• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠-肾轴:胃肠道疾病与肾脏疾病之间的潜在联系

The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders.

作者信息

Lehto Markku, Groop Per-Henrik

机构信息

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.

Abdominal Center of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

出版信息

Front Endocrinol (Lausanne). 2018 Sep 19;9:553. doi: 10.3389/fendo.2018.00553. eCollection 2018.

DOI:10.3389/fendo.2018.00553
PMID:30283404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6157406/
Abstract

Diabetic kidney disease (DKD) is a devastating condition associated with increased morbidity and premature mortality. The etiology of DKD is still largely unknown. However, the risk of DKD development and progression is most likely modulated by a combination of genetic and environmental factors. Patients with autoimmune diseases, like type 1 diabetes, inflammatory bowel disease, and celiac disease, share some genetic background. Furthermore, gastrointestinal disorders are associated with an increased risk of kidney disease, although the true mechanisms have still to be elucidated. Therefore, the principal aim of this review is to evaluate the impact of disturbances in the gastrointestinal tract on the development of renal disorders.

摘要

糖尿病肾病(DKD)是一种具有高发病率和过早死亡率的严重疾病。DKD的病因在很大程度上仍然未知。然而,DKD发生和进展的风险很可能是由遗传和环境因素共同调节的。患有自身免疫性疾病的患者,如1型糖尿病、炎症性肠病和乳糜泻,具有一些共同的遗传背景。此外,胃肠道疾病与肾脏疾病风险增加有关,尽管其真正机制仍有待阐明。因此,本综述的主要目的是评估胃肠道紊乱对肾脏疾病发展的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a9c/6157406/69e560875636/fendo-09-00553-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a9c/6157406/5976ed90c273/fendo-09-00553-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a9c/6157406/69e560875636/fendo-09-00553-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a9c/6157406/5976ed90c273/fendo-09-00553-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a9c/6157406/69e560875636/fendo-09-00553-g0002.jpg

相似文献

1
The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders.肠-肾轴:胃肠道疾病与肾脏疾病之间的潜在联系
Front Endocrinol (Lausanne). 2018 Sep 19;9:553. doi: 10.3389/fendo.2018.00553. eCollection 2018.
2
Diabetic kidney disease in Australia: current burden and future projections.澳大利亚的糖尿病肾病:当前负担与未来预测
Nephrology (Carlton). 2014 Aug;19(8):450-8. doi: 10.1111/nep.12281.
3
Markers of and risk factors for the development and progression of diabetic kidney disease.糖尿病肾病的发生和进展的标志物及危险因素。
Am J Kidney Dis. 2014 Feb;63(2 Suppl 2):S39-62. doi: 10.1053/j.ajkd.2013.10.048.
4
Biomarkers of diabetic nephropathy: A 2017 update.糖尿病肾病的生物标志物:2017 年更新。
Crit Rev Clin Lab Sci. 2017 Aug;54(5):326-342. doi: 10.1080/10408363.2017.1377682. Epub 2017 Sep 28.
5
Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.压力与肠道:病理生理学、临床后果、诊断方法和治疗选择。
J Physiol Pharmacol. 2011 Dec;62(6):591-9.
6
Rationale and strategies for early detection and management of diabetic kidney disease.糖尿病肾病早期检测与管理的基本原理和策略
Mayo Clin Proc. 2008 Dec;83(12):1373-81. doi: 10.1016/S0025-6196(11)60786-6.
7
The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.沙特糖尿病肾病研究(沙特-DKD):临床特征与生化参数
Ann Saudi Med. 2018 Jan-Feb;38(1):46-56. doi: 10.5144/0256-4947.2018.03.01.1010. Epub 2018 Jan 3.
8
Non-Diabetic Kidney Disease in Type 2 Diabetic Patients: Prevalence, Clinical Predictors and Outcomes.2型糖尿病患者中的非糖尿病肾病:患病率、临床预测因素及预后
Kidney Blood Press Res. 2017;42(5):886-893. doi: 10.1159/000484538. Epub 2017 Nov 1.
9
An evaluation of the diabetic kidney disease definition in chinese patients diagnosed with type 2 diabetes mellitus.对诊断为2型糖尿病的中国患者糖尿病肾病定义的评估。
J Int Med Res. 2009 Sep-Oct;37(5):1493-500. doi: 10.1177/147323000903700526.
10
Diabetic kidney disease: a report from an ADA Consensus Conference.糖尿病肾病:ADA 共识会议报告。
Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.

引用本文的文献

1
CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implications.CTSS和CD53:糖尿病肾病发病机制中新兴的m6A甲基化标志物及其临床意义。
BMC Nephrol. 2025 Jul 7;26(1):357. doi: 10.1186/s12882-025-04314-w.
2
The Regulatory Effect of Human Umbilical Cord Mesenchymal Stem Cells on the Gut Microbiota in Diabetic Nephropathy Rats.人脐带间充质干细胞对糖尿病肾病大鼠肠道微生物群的调节作用
Iran J Biotechnol. 2025 Jan 1;23(1). doi: 10.30498/ijb.2025.472772.3975. eCollection 2025 Jan.
3
Fecal Calprotectin as a Prognostic Biomarker for Mortality and Renal Outcomes in Chronic Kidney Disease.

本文引用的文献

1
Translocation of a gut pathobiont drives autoimmunity in mice and humans.肠道共生病原体易位导致小鼠和人类发生自身免疫。
Science. 2018 Mar 9;359(6380):1156-1161. doi: 10.1126/science.aar7201.
2
Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis.人类 ALPI 缺乏症可引起炎症性肠病,并突出了肠道内稳态的一个关键机制。
EMBO Mol Med. 2018 Apr;10(4). doi: 10.15252/emmm.201708483.
3
Extended Mortality and Chronic Kidney Disease After Septic Acute Kidney Injury.脓毒症急性肾损伤后延长的死亡率和慢性肾脏病。
粪便钙卫蛋白作为慢性肾脏病死亡率和肾脏结局的预后生物标志物
Biomolecules. 2025 Apr 10;15(4):557. doi: 10.3390/biom15040557.
4
Crohn's disease but not ulcerative colitis elevated risk of end-stage renal disease and mortality: A Taiwan retrospective cohort study.克罗恩病而非溃疡性结肠炎会增加终末期肾病风险和死亡率:一项台湾回顾性队列研究。
Medicine (Baltimore). 2025 Apr 4;104(14):e42026. doi: 10.1097/MD.0000000000042026.
5
Optimizing chronic kidney disease management: The potential of a multi-strain probiotic formulation.优化慢性肾脏病管理:多菌株益生菌制剂的潜力。
World J Nephrol. 2025 Mar 25;14(1):101515. doi: 10.5527/wjn.v14.i1.101515.
6
Dextran sodium sulfate-induced colitis in male BALB/c mice leads to albuminuria and increased markers of inflammation and tissue damage in the kidney.葡聚糖硫酸钠诱导的雄性BALB/c小鼠结肠炎会导致蛋白尿以及肾脏中炎症和组织损伤标志物增加。
Physiol Rep. 2025 Mar;13(5):e70161. doi: 10.14814/phy2.70161.
7
The Gut-Kidney Axis in Chronic Kidney Diseases.慢性肾脏病中的肠-肾轴
Diagnostics (Basel). 2024 Dec 25;15(1):21. doi: 10.3390/diagnostics15010021.
8
Association of live microbes intake and risk of all-cause, cardiovascular disease, and cancer-related mortality in patients with chronic kidney disease.慢性肾病患者摄入活微生物与全因、心血管疾病及癌症相关死亡率的关联
Ren Fail. 2025 Dec;47(1):2449196. doi: 10.1080/0886022X.2024.2449196. Epub 2025 Jan 6.
9
Gut microbiota and bile acids: Metabolic interactions and impacts on diabetic kidney disease.肠道微生物群与胆汁酸:代谢相互作用及其对糖尿病肾病的影响
Curr Res Microb Sci. 2024 Nov 17;7:100315. doi: 10.1016/j.crmicr.2024.100315. eCollection 2024.
10
Causal Relationships Between Gut Microbiota, Metabolites, and Diabetic Nephropathy: Insights from a Two-Sample Mendelian Randomization Analysis.肠道微生物群、代谢物与糖尿病肾病之间的因果关系:来自两样本孟德尔随机化分析的见解
Int J Nephrol Renovasc Dis. 2024 Dec 10;17:319-332. doi: 10.2147/IJNRD.S489074. eCollection 2024.
J Intensive Care Med. 2020 Jun;35(6):527-535. doi: 10.1177/0885066618764617. Epub 2018 Mar 18.
4
A missense mutation in the plasminogen gene, within the plasminogen kringle 3 domain, in hereditary angioedema with normal C1 inhibitor.在遗传性血管性水肿伴正常C1抑制剂患者中,纤溶酶原kringle 3结构域内的纤溶酶原基因发生错义突变。
Biochem Biophys Res Commun. 2018 Mar 25;498(1):193-198. doi: 10.1016/j.bbrc.2017.12.060.
5
The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.血浆激肽释放酶-激肽原系统在小鼠结肠炎发病机制中起关键作用。
Front Immunol. 2018 Feb 6;9:21. doi: 10.3389/fimmu.2018.00021. eCollection 2018.
6
Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis.服用抗高血压药物患者的急性肾损伤和感染:一项自我对照病例系列分析。
Clin Epidemiol. 2018 Jan 30;10:187-202. doi: 10.2147/CLEP.S146757. eCollection 2018.
7
The gut microbiota as a novel regulator of cardiovascular function and disease.肠道微生物群作为心血管功能和疾病的新型调节因子。
J Nutr Biochem. 2018 Jun;56:1-15. doi: 10.1016/j.jnutbio.2017.12.010. Epub 2017 Dec 27.
8
Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?肠道微生物群和益生菌干预:管理心血管代谢疾病和慢性肾脏病的潜在治疗靶点?
Pharmacol Res. 2018 Apr;130:152-163. doi: 10.1016/j.phrs.2018.01.020. Epub 2018 Feb 14.
9
Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis.感染因子与炎症:微生物群在自身免疫性关节炎中的作用
Front Microbiol. 2018 Jan 16;8:2696. doi: 10.3389/fmicb.2017.02696. eCollection 2017.
10
Excess Mortality in Patients With Type 1 Diabetes Without Albuminuria-Separating the Contribution of Early and Late Risks.1 型糖尿病无白蛋白尿患者的超额死亡率——早期和晚期风险的贡献。
Diabetes Care. 2018 Apr;41(4):748-754. doi: 10.2337/dc17-1618. Epub 2018 Jan 29.